secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001104659-25-044352
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist reports record Q2 revenue $92.8M; spins out DNA data storage as Atlas with $155M investment
--------------------------------------------------------------------------------

- Record Q2 revenue $92.8M (+23% YoY); gross margin 49.6% vs 41.0%.
- Net loss $39.3M ($0.66/sh) vs $45.5M ($0.79); adjusted EBITDA loss improved to $(14.8)M.
- Spun out DNA data storage as Atlas Data Storage with $155M investment from ARCH, Deerfield, Bezos Expeditions, and others.
- Atlas CEO Varun Mehta (ex-Nimble Storage) leads; Twist retains minority stake, $2.5M cash, $2M note, up to $75M milestones.
- Guidance: FY2025 revenue $372-379M; expect gross margin >50% in Q4; adjusted EBITDA breakeven by end of FY2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465925044352/0001104659-25-044352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465925044352/tm2513694d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-044352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer